Cargando…

Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice

Conventional pertussis animal models deliver hundreds of thousands of Bordetella pertussis bacteria deep into the lungs, rapidly inducing severe pneumonic pathology and a robust immune response. However, human infections usually begin with colonization and growth in the upper respiratory tract. We i...

Descripción completa

Detalles Bibliográficos
Autores principales: Soumana, Illiassou Hamidou, Linz, Bodo, Dewan, Kalyan K., Sarr, Demba, Gestal, Monica C., Howard, Laura K., Caulfield, Amanda D., Rada, Balázs, Harvill, Eric T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314809/
https://www.ncbi.nlm.nih.gov/pubmed/34286682
http://dx.doi.org/10.3201/eid2708.203566
_version_ 1783729610949656576
author Soumana, Illiassou Hamidou
Linz, Bodo
Dewan, Kalyan K.
Sarr, Demba
Gestal, Monica C.
Howard, Laura K.
Caulfield, Amanda D.
Rada, Balázs
Harvill, Eric T.
author_facet Soumana, Illiassou Hamidou
Linz, Bodo
Dewan, Kalyan K.
Sarr, Demba
Gestal, Monica C.
Howard, Laura K.
Caulfield, Amanda D.
Rada, Balázs
Harvill, Eric T.
author_sort Soumana, Illiassou Hamidou
collection PubMed
description Conventional pertussis animal models deliver hundreds of thousands of Bordetella pertussis bacteria deep into the lungs, rapidly inducing severe pneumonic pathology and a robust immune response. However, human infections usually begin with colonization and growth in the upper respiratory tract. We inoculated only the nasopharynx of mice to explore the course of infection in a more natural exposure model. Nasopharyngeal colonization resulted in robust growth in the upper respiratory tract but elicited little immune response, enabling prolonged and persistent infection. Immunization with human acellular pertussis vaccine, which prevents severe lung infections in the conventional pneumonic infection model, had little effect on nasopharyngeal colonization. Our infection model revealed that B. pertussis can efficiently colonize the mouse nasopharynx, grow and spread within and between respiratory organs, evade robust host immunity, and persist for months. This experimental approach can measure aspects of the infection processes not observed in the conventional pneumonic infection model.
format Online
Article
Text
id pubmed-8314809
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-83148092021-08-07 Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice Soumana, Illiassou Hamidou Linz, Bodo Dewan, Kalyan K. Sarr, Demba Gestal, Monica C. Howard, Laura K. Caulfield, Amanda D. Rada, Balázs Harvill, Eric T. Emerg Infect Dis Research Conventional pertussis animal models deliver hundreds of thousands of Bordetella pertussis bacteria deep into the lungs, rapidly inducing severe pneumonic pathology and a robust immune response. However, human infections usually begin with colonization and growth in the upper respiratory tract. We inoculated only the nasopharynx of mice to explore the course of infection in a more natural exposure model. Nasopharyngeal colonization resulted in robust growth in the upper respiratory tract but elicited little immune response, enabling prolonged and persistent infection. Immunization with human acellular pertussis vaccine, which prevents severe lung infections in the conventional pneumonic infection model, had little effect on nasopharyngeal colonization. Our infection model revealed that B. pertussis can efficiently colonize the mouse nasopharynx, grow and spread within and between respiratory organs, evade robust host immunity, and persist for months. This experimental approach can measure aspects of the infection processes not observed in the conventional pneumonic infection model. Centers for Disease Control and Prevention 2021-08 /pmc/articles/PMC8314809/ /pubmed/34286682 http://dx.doi.org/10.3201/eid2708.203566 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Soumana, Illiassou Hamidou
Linz, Bodo
Dewan, Kalyan K.
Sarr, Demba
Gestal, Monica C.
Howard, Laura K.
Caulfield, Amanda D.
Rada, Balázs
Harvill, Eric T.
Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice
title Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice
title_full Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice
title_fullStr Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice
title_full_unstemmed Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice
title_short Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice
title_sort modeling immune evasion and vaccine limitations by targeted nasopharyngeal bordetella pertussis inoculation in mice
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314809/
https://www.ncbi.nlm.nih.gov/pubmed/34286682
http://dx.doi.org/10.3201/eid2708.203566
work_keys_str_mv AT soumanailliassouhamidou modelingimmuneevasionandvaccinelimitationsbytargetednasopharyngealbordetellapertussisinoculationinmice
AT linzbodo modelingimmuneevasionandvaccinelimitationsbytargetednasopharyngealbordetellapertussisinoculationinmice
AT dewankalyank modelingimmuneevasionandvaccinelimitationsbytargetednasopharyngealbordetellapertussisinoculationinmice
AT sarrdemba modelingimmuneevasionandvaccinelimitationsbytargetednasopharyngealbordetellapertussisinoculationinmice
AT gestalmonicac modelingimmuneevasionandvaccinelimitationsbytargetednasopharyngealbordetellapertussisinoculationinmice
AT howardlaurak modelingimmuneevasionandvaccinelimitationsbytargetednasopharyngealbordetellapertussisinoculationinmice
AT caulfieldamandad modelingimmuneevasionandvaccinelimitationsbytargetednasopharyngealbordetellapertussisinoculationinmice
AT radabalazs modelingimmuneevasionandvaccinelimitationsbytargetednasopharyngealbordetellapertussisinoculationinmice
AT harvillerict modelingimmuneevasionandvaccinelimitationsbytargetednasopharyngealbordetellapertussisinoculationinmice